India Glycols (INDIAGLYCO) | Financial Analysis & Statements
India Glycols Ltd. Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
10.4B
Gross Profit
3.6B
34.89%
Operating Income
1.2B
11.07%
Net Income
732.5M
7.04%
EPS (Diluted)
₹11.83
Balance Sheet Metrics
Total Assets
61.8B
Total Liabilities
39.2B
Shareholders Equity
22.6B
Debt to Equity
1.74
Cash Flow Metrics
Operating Cash Flow
1.0B
Free Cash Flow
-426.9M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
India Glycols Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 36.9B | 32.7B | 25.8B | 28.1B | 22.5B |
| Cost of Goods Sold | 24.9B | 22.1B | 16.3B | 19.7B | 15.4B |
| Gross Profit | 12.0B | 10.6B | 9.5B | 8.5B | 7.1B |
| Gross Margin % | 32.5% | 32.3% | 36.7% | 30.0% | 31.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 1.2B | 1.3B | 1.1B | 1.4B | 1.1B |
| Other Operating Expenses | 4.5B | 4.2B | 4.8B | 2.5B | 2.8B |
| Total Operating Expenses | 5.7B | 5.5B | 5.9B | 4.0B | 3.9B |
| Operating Income | 4.4B | 3.2B | 2.3B | 3.2B | 2.1B |
| Operating Margin % | 11.9% | 9.8% | 9.1% | 11.4% | 9.2% |
| Non-Operating Items | |||||
| Interest Income | 143.8M | 235.8M | 247.2M | 242.5M | 92.9M |
| Interest Expense | 1.4B | 1.1B | 850.1M | 579.9M | 713.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 2.9B | 2.2B | 1.7B | 3.7B | 1.2B |
| Income Tax | 614.0M | 503.2M | 239.6M | 394.3M | 112.8M |
| Effective Tax Rate % | 21.0% | 22.5% | 14.5% | 10.7% | 9.4% |
| Net Income | 2.3B | 1.7B | 1.4B | 3.4B | 1.3B |
| Net Margin % | 6.3% | 5.3% | 5.5% | 12.1% | 5.9% |
| Key Metrics | |||||
| EBITDA | 5.4B | 4.3B | 3.1B | 4.2B | 2.8B |
| EPS (Basic) | ₹37.29 | ₹55.87 | ₹45.55 | ₹109.77 | ₹42.51 |
| EPS (Diluted) | ₹37.29 | ₹55.87 | ₹45.55 | ₹109.77 | ₹42.51 |
| Basic Shares Outstanding | 61923000 | 30961500 | 30961500 | 30961500 | 30961500 |
| Diluted Shares Outstanding | 61923000 | 30961500 | 30961500 | 30961500 | 30961500 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
India Glycols Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 68.4M | 269.6M | 19.7M | 70.5M | 33.9M |
| Short-term Investments | 478.6M | 476.9M | 457.0M | 389.4M | 1.7B |
| Accounts Receivable | 3.6B | 3.8B | 4.3B | 4.0B | 3.6B |
| Inventory | 11.7B | 11.1B | 7.5B | 6.9B | 6.1B |
| Other Current Assets | 1.4B | 1.8B | 1.7B | 2.0B | 1.7B |
| Total Current Assets | 18.2B | 19.4B | 16.5B | 16.1B | 17.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.1B | 366.1M | 213.3M | 217.2M | 229.9M |
| Goodwill | 13.7M | 16.3M | 19.0M | 16.5M | 18.7M |
| Intangible Assets | 13.7M | 16.3M | 19.0M | 16.5M | 18.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 63.8M | 53.9M | 80.4M | 10.8M | 166.3M |
| Total Non-Current Assets | 43.6B | 36.7B | 32.1B | 30.2B | 24.1B |
| Total Assets | 61.8B | 56.2B | 48.6B | 46.3B | 41.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 10.7B | 11.7B | 8.0B | 6.8B | 6.3B |
| Short-term Debt | 7.8B | 6.0B | 5.5B | 5.1B | 6.2B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.8B | 2.9B | 2.4B | 2.9B | 2.6B |
| Total Current Liabilities | 23.2B | 23.7B | 18.6B | 17.5B | 17.7B |
| Non-Current Liabilities | |||||
| Long-term Debt | 11.1B | 7.5B | 5.7B | 5.4B | 5.2B |
| Deferred Tax Liabilities | 4.4B | 4.0B | 3.6B | 3.4B | 3.6B |
| Other Non-Current Liabilities | 28.4M | 29.6M | 1.2B | 1.9B | 2.6B |
| Total Non-Current Liabilities | 16.0B | 11.9B | 10.9B | 11.1B | 11.8B |
| Total Liabilities | 39.2B | 35.7B | 29.6B | 28.6B | 29.5B |
| Equity | |||||
| Common Stock | 309.6M | 309.6M | 309.6M | 309.6M | 309.6M |
| Retained Earnings | 20.7B | 18.7B | 17.2B | 16.1B | 9.8B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 22.6B | 20.5B | 19.0B | 17.7B | 11.7B |
| Key Metrics | |||||
| Total Debt | 18.9B | 13.5B | 11.1B | 10.4B | 11.4B |
| Working Capital | -5.0B | -4.3B | -2.2B | -1.4B | -575.0M |
Balance Sheet Composition
India Glycols Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 2.5B | 2.1B | 1.5B | 3.5B | 1.2B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 1.1B | -2.9B | 232.4M | -1.5B | 624.2M |
| Operating Cash Flow | 5.0B | 160.3M | 2.6B | 2.4B | 2.5B |
| Investing Activities | |||||
| Capital Expenditures | -7.5B | -5.4B | -4.3B | -3.8B | -1.5B |
| Acquisitions | - | - | 0 | 4.6B | 0 |
| Investment Purchases | - | - | - | - | 0 |
| Investment Sales | 0 | 1.8M | 553.1M | 1.5M | 0 |
| Investing Cash Flow | -7.5B | -5.4B | -3.8B | 622.5M | -1.7B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -245.9M | -229.7M | -230.4M | -183.9M | -3.8M |
| Debt Issuance | 8.6B | 4.6B | 3.0B | 3.2B | 3.0B |
| Debt Repayment | -3.8B | -2.4B | -1.7B | -4.1B | -1.6B |
| Financing Cash Flow | 4.6B | 2.0B | 1.1B | -1.1B | 1.0B |
| Free Cash Flow | -4.0B | -1.1B | -1.1B | -2.6B | -115.5M |
| Net Change in Cash | 2.1B | -3.2B | -159.3M | 1.9B | 1.9B |
Cash Flow Trend
India Glycols Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
22.62
Price to Book
2.53
Price to Sales
1.60
PEG Ratio
1.29
Profitability Ratios
Profit Margin
6.59%
Operating Margin
12.18%
Return on Equity
10.24%
Return on Assets
3.74%
Financial Health
Current Ratio
0.83
Debt to Equity
85.85
Beta
0.17
Per Share Data
EPS (TTM)
₹43.19
Book Value per Share
₹386.68
Revenue per Share
₹656.23
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| INDIAGLYCO | 65.3B | 22.62 | 2.53 | 10.24% | 6.59% | 85.85 |
| Navin Fluorine | 322.4B | 57.84 | 8.89 | 10.99% | 17.74% | 32.68 |
| Deepak Nitrite | 230.5B | 43.19 | 4.18 | 12.85% | 6.71% | 22.41 |
| Tata Chemicals | 176.6B | 108.83 | 0.79 | 1.04% | 1.23% | 32.13 |
| Deepak Fertilisers | 158.4B | 18.07 | 2.43 | 14.93% | 7.84% | 62.05 |
| Archean Chemical | 73.7B | 50.29 | 3.87 | 8.70% | 13.01% | 14.78 |
Financial data is updated regularly. All figures are in the company's reporting currency.





